Gaps in approaches to sexual health and pharmaceutical care for cisgender women who have sex with women. A literature review. Lacunas nas abordagens de saúde sexual e cuidado farmacêutico para mulheres cisgênero que fazem sexo com mulheres. Uma revisão da literatura.
BJHP-V6N3
PDF (Português (Brasil))

Keywords

Sexual health
Sexual and gender minorities
Female homosexuality

How to Cite

Freitas Couto, A. L., & Conceição de Oliveira Sebastião, E. (2024). Gaps in approaches to sexual health and pharmaceutical care for cisgender women who have sex with women. A literature review. Lacunas nas abordagens de saúde sexual e cuidado farmacêutico para mulheres cisgênero que fazem sexo com mulheres. Uma revisão da literatura. Brazilian Journal of Health and Pharmacy, 6(3), 01–11. https://doi.org/10.29327/226760.6.3-2

Abstract

This literature review provides relevant information on sexual health and pharmaceutical care for women who have sex with women (WSW). The objective of this study was to conduct a systematic review of the literature on pharmaceutical care focused on WSW sexual health, aiming to provide an overview of the topic and discuss the approaches and protocols currently available for this population. The review included studies and protocols published between 2018 and 2023, using the keywords: ‘sexual health,’ ‘women who have sex with women,’ ‘pharmaceutical care,’ and ‘LGBTQIA+ health’ in the PubMed, Scielo, Google Scholar databases, as well as various governmental and non-governmental databases. Among the resulting articles, two publications stood out for making significant contributions to pharmaceutical care targeted at WSW and the LGBTQIAP+ community more broadly. The findings of this review underscore the urgent need for greater awareness and visibility of WSW sexual health, as well as the promotion of inclusive health policies that address the unique needs of this population. The study also emphasizes the importance of revising health academic curricula to more effectively incorporate LGBTQIAP+ topics and suggests public health initiatives to ensure empathetic and equitable pharmaceutical care. Health equity for WSW, as concluded, will only be achieved through structural efforts that combat invisibility and ensure adequate care, regardless of sexual orientation or gender identity

https://doi.org/10.29327/226760.6.3-2
PDF (Português (Brasil))